Affinity Investment Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Affinity Investment Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,818	Closed	-$690K	–	173
2021 Q1	$690K	Sell	7,818 -450	-5%	-$41.8K	0.25%	115
2020 Q4	$791K	Sell	8,268 -1,810	-18%	-$187K	0.32%	91
2020 Q3	$1.14M	Sell	10,078 -3,186	-24%	-$335K	0.5%	56
2020 Q2	$1.31M	Hold	13,264	–	–	0.62%	54
2020 Q1	$854K	Buy	13,264 +4,320	+48%	+$303K	0.44%	52
2019 Q4	$533K	Hold	8,944	–	–	0.19%	86
2019 Q3	$528K	Buy	+8,944	New	+$571K	0.17%	76

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Affinity Investment Advisors's TNDM Position: Q2 2021 in Review

Affinity Investment Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 7,818 shares — an estimated $690K sold.

Affinity Investment Advisors first reported a position in TNDM in Q3 2019 and held it in 7 quarters. The position peaked at $1.31M in Q2 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

Affinity Investment Advisors reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
Affinity Investment Advisors sold 7,818 Tandem Diabetes Care shares in Q2 2021, an estimated $690K.
Affinity Investment Advisors first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 7 quarters.
Affinity Investment Advisors's Tandem Diabetes Care position peaked at $1.31M in Q2 2020.
303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Affinity Investment Advisors's 13F filing for Q2 2021, filed 9 Aug 2021.